Oracle Buys ClearTrial

Adds Leading Cloud-based Clinical Trial Operations and Analytics Applications to Oracle Health Sciences Suite

For more, click the link below:

http://www.oracle.com/us/corporate/press/1570030

Oracle Announces Next Generation of Oracle® Health Sciences Clinical Development Analytics

Note to visitors: The Palo-Negro-Blog is no longer being actively maintained.  For more up-to-date news and information, please visit the successor blogs:  http://JBK-BizTech.blogspot.com and http://JBK-Current-Events.blogspot.com

Oracle Announces Next Generation of Oracle® Health Sciences Clinical Development Analytics

New Features Expand Visibility into Clinical Programs to Help Increase Productivity and Clinical Effectiveness while Helping to Reduce Costs

DIA Annual EuroMeeting, Copenhagen, Denmark – March 27, 2012

News Facts

Focused on helping health sciences organizations increase the productivity and effectiveness of their product development programs, Oracle Health Sciences today introduced the newest version of Oracle® Health Sciences Clinical Development Analytics.

Driven by input from industry partners, the comprehensive business intelligence application includes new functionality that expands visibility into clinical programs and studies, improves the quality and timeliness of clinical trial data and helps to simplify and prioritize the rapidly expanding responsibilities of study managers, clinical data managers, and site monitors.

The enhanced solution helps to increase resource utilization by delivering advanced dashboards specifically tailored to clinical trial roles. It features expanded drill-down functionality and key performance indicators that identify areas requiring action or attention, such as targeting underperforming sites.

The solution enables organizations to merge data from multiple clinical trial sources, providing a unified view across operational systems on a single screen. New de-duplication technology supports reports that combine both clinical operations and data management information to monitor enrollment progress, optimize productivity at site visits and help to reduce monitoring-related travel expenses.

Oracle Health Sciences Clinical Development Analytics also delivers visibility across the entire portfolio of clinical trials, which enables greater insight into subject recruitment and site performance to empower managers and clinical monitors to better target resources to key sites which will help accelerate trial completion.

With more than 100 pre-built reports and over 500 pre-built measurements and attributes for custom reporting, Oracle Health Sciences Clinical Development Analytics can provide immediate business benefit out of the box, while providing an extensible framework for adding additional metrics aligned to targeted business processes.

• To enable anytime, anywhere access, the solution can be used in conjunction with Oracle Business Intelligence Mobile application for Apple iPhone and iPad to give mobile users access to the latest performance management information.

Supporting Quote

“Clinical trial sponsors and their CRO partners, navigating increasingly complex and lengthy development cycles, are intently focused on improving data quality and clinical program productivity while reducing costs,” said Neil de Crescenzo, senior vice president and general manager, Oracle Health Sciences. “The newest version of Oracle Health Sciences Clinical Development Analytics, which features integrated content, expanded dashboards, and optimized reporting, delivers the insight that study sponsors, managers, and monitors require to achieve these goals and accelerate the delivery of new products to the market.”

Supporting Resources

Oracle in Health Sciences

Follow Oracle Health Sciences on Twitter

Join the Oracle Health Sciences Community on Facebook

Oracle Health Sciences on YouTube

About Oracle

Oracle engineers hardware and software to work together in the cloud and in your data center.  For more information about Oracle (NASDAQ:ORCL), visit www.oracle.com.

About Oracle in Industries

Oracle industry solutions leverage the company’s best-in-class portfolio of products to address complex business processes relevant to health sciences, helping speed time to market, reduce costs, and gain a competitive edge.

Trademark

Oracle and Java are registered trademarks of Oracle and/or its affiliates. Other names may be trademarks of their respective owners.

# # #

Centricity Cardio Enterprise Unveiled at ACC 2012

22 March 2012

Centricity Cardio Enterprise Unveiled at ACC 2012

 

GE Healthcare’s New Cardiovascular IT Solution Enables Full Clinical Access, Enhanced Physician Productivity, and Improved Charge Capture Accuracy

CHICAGO -- March 22, 2012 – At the 61st Meeting of the American College of Cardiology in Chicago next week, GE Healthcare is introducing Centricity* Cardio Enterprise, a new and comprehensive IT solution that offers cardiologists a single point of access to patient data, images and reports across the continuum of care while enhancing physician productivity and improving charge capture accuracy. Centricity Cardio Enterprise enables the cardiovascular care area with configurable workflow, tools, and reports that can be shared across multiple facilities and organizations.

Cardiologists can be more mobile than ever before using Centricity Cardio Enterprise. Whether a clinician is in the lab, on the floor, in the OR, in their office across town, or at home over the weekend - patient data and diagnostic-quality images are available at their fingertips when they need it. Centricity Cardio Enterprise allows cardiologists to easily and securely access the complete patient cardiovascular record for rapid and more informed clinical decision making - determinations that can often be life impacting for patients.

“The industry needs a web-enabled solution to truly move to the next generation of cardiovascular care,” said Nadim Daher, principal analyst – Medical Imaging and Imaging Informatics, Frost and Sullivan. “Today’s cardiologist doesn’t have time to ensure she’s in the same place every time she wants to diagnose a patient. The industry needs to evolve to meet the clinicians’ needs. Centricity Cardio Enterprise fits that need.”

CIOs and cardiology administrators will appreciate Centricity Cardio Enterprise’s scalability and IT infrastructure, leveraging GE Healthcare’s vendor neutral archiving platform. It provides standards-based image and document storage with an ability to intelligently enforce lifecycle management policies. Centricity Cardio Enterprise also automates post-procedural patient outcomes management to not only help customers in meeting today’s regulatory needs, but also prepare them for upcoming changes in the future.

“We value our partnership with GE and its focus on providing Clinical IT solutions that simplify access to critical patient information for our clinicians,” said Daniel Salzberg, Administrative Director – Information Services at Bon Secours Health System in Virginia. “We are excited about the possibilities of the new Cardiovascular IT platform, Centricity Cardio Enterprise, which provides a comprehensive solution across the cardiovascular care area.”

“This is the future of cardiovascular patient care,” said Michael Jackman, vice president and general manager of GE Healthcare IT. “We’re delivering greater value to cardiologists with Centricity Cardio Enterprise—particularly with its location agnostic access and productivity enhancement capabilities. Less time entering data or manually reporting on a cardiovascular IT solution means more time spent on patient care.”

*Centricity is a registered trademark of General Electric Company.

EZ DERM Electronic Health Record App Now Powered by Nuance Healthcare 360 Development Platform

EZ DERM Electronic Health Record App Now Powered by Nuance Healthcare 360 Development Platform

EZ DERM's 3-D Mapping App Offers Dermatologists Voice-Powered, Mobile Clinical Documentation Capture

BURLINGTON, Mass., – March 20, 2012 – Today, Nuance Communications, Inc., and EZ DERM, LLC™ announce that the EZ DERM electronic health record (EHR) iPad app is now powered by the Nuance Healthcare 360 | Development Platform. The EZ DERM EHR joins a growing list of healthcare apps that incorporate Nuance’s cloud-based, medical speech recognition technology to allow physicians to use their voice for app interaction and navigation, as well as for clinical documentation while on-the-go.

According to a recent survey from the American Academy of Dermatology, only 33.7 percent of dermatologists are satisfied with their current EHR. The EZ DERM iPad app, which is being launched this week at the 70th Annual American Academy of Dermatology conference, aims to address current frustrations with EHR technology already on the market. EZ DERM is the only dermatology-specific EHR that is solely based on the iPad® mobile platform and employs patent-pending 3D anatomical maps of the human body, Nuance speech recognition, and clinical decision-support.

“As a dermatologist, I have first-hand insight into the problems plaguing today’s EHR platforms, most of which are based on the cumbersome desktop or laptop platforms that rely on keyboard data entry. Allowing dermatologists, who can see up to a hundred patients a day, a touch-based and speech-driven technology was a logical solution for busy dermatology practices,” said Srdjan Prodanovich, MD, FAAD and founder of EZ DERM, LLC. “The EZ DERM app was specifically designed to improve care and help dermatologists manage patients in an intuitive, efficient and mobile way. Leveraging the 360 | Development Platform was a no-brainer for us. Nuance is the leader in medical speech recognition and offers a proven benefit for our app that not only differentiates it, but makes it highly usable.”

With Nuance Healthcare-powered mobile apps, clinicians can use their voice for app interaction and navigation, as well as for mobile clinical documentation, leading to the following benefits:

• Increased productivity as a result of speaking vs. typing and, in turn, improved physician satisfaction with mobile device use;
• Cost savings from eliminating traditional documentation processes involving paper, medical transcription support and caregiver time; and
• Highly-detailed patient notes that capture unique details from the patient encounter at the point-of-care.

“There’s broad physician demand for health IT applications, specifically EHRs, to be more user-friendly and intuitive,” said Jonathon Dreyer, Nuance Healthcare mobile solutions. “We’ve designed the 360 | Development Platform with the industry’s ease-of-use demand in mind, and to provide developers with an easy to implement tool that will differentiate and enhance their m-Health applications. As the mobile clinician becomes more commonplace, we expect continued integration of our speech-enabled development platform as a means to drive an array of voice-driven healthcare apps aimed at simplifying the mobile experience.”

The Nuance Healthcare 360 | Development Platform supports multiple devices and operating systems. By providing all CPU intensive voice and language processing in the cloud, this platform enables speech and language understanding technologies to be integrated as part of browser-based applications, mobile applications and thin-client desktop solutions.

To learn more about the EZ DERM app powered by Nuance Healthcare’s medical speech recognition and to view a video demo, please visit: www.ezderm.com.

EZ DERM, LLC™ is an international technology company that consists of physicians, software engineers, mathematicians, web developers, graphic designers, 3D designers and 3D animators, all focused on creating world-class mobile solutions for the field of medicine. The company's main focus is to improve the quality of patient care by empowering physicians with state-of-the-art mobile electronic health record (EHR) technology. The EZ DERM iPad app enables physicians and their staff to intuitively document patient encounters, access anatomically accurate three-dimensional body maps, and leverage clinical decision-support, iPad®-based telephony, video-conferencing, text messaging and speech recognition capabilities in the palm of their hand. For more information on EZ DERM visit: www.ezderm.com

Nuance Healthcare

Nuance Healthcare, a division of Nuance Communications, is the market leader in providing clinical understanding solutions that accurately capture and transform the patient story into meaningful, actionable information. Thousands of hospitals, providers and payers worldwide trust Nuance voice-enabled clinical documentation and analytics solutions to facilitate smarter, more efficient decisions across the healthcare enterprise. These solutions are proven to increase clinician satisfaction and HIT adoption, supporting organizations to achieve Meaningful Use of EHR systems and transform to the accountable care model. Recognized as “Best-in-KLAS” 2004-2011 for Voice Recognition we invite you to learn more, http://www.nuance.com/for-healthcare/index.htm.

Connect with Nuance Healthcare on:

For the Health of IT blog: http://nuancehealthcareblog.com/

Twitter: http://bit.ly/NuanceHCTwitter

Facebook: http://on.fb.me/NuanceHCfacebook

YouTube: http://bit.ly/NuanceHCYouTube

LinkedIn: http://linkd.in/NuanceHCLinkedIn

Nuance Communications, Inc. (NASDAQ: NUAN) is a leading provider of voice and language solutions for businesses and consumers around the world. Its technologies, applications and services make the user experience more compelling by transforming the way people interact with devices and systems. Every day, millions of users and thousands of businesses experience Nuance’s proven applications. For more information, please visit www.nuance.com.

Nuance to Acquire Transcend

Nuance to Acquire Transcend


Accretive Transaction to Accelerate Adoption of Nuance Healthcare Solutions by Small- to Mid-Sized Hospital Market, Bring Strong Customer Base and Recurring Revenue

With Transcend, Nuance will accelerate access to and expand its customer base within the small- to mid-size hospital market, which comprises approximately 90 percent of hospitals in the U.S. and increasingly demands cost effective, voice-enabled, clinical documentation solutions to achieve Meaningful Use and the transition to ICD-10. With Nuance’s voice-enabled and Clinical Language Understanding technologies and deep electronic health record (EHR) integration, combined with Transcend’s high-quality transcription and editing services, hospitals can make clinical documentation and workflow more productive and cost efficient and extract greater value from clinical information.

“The acquisition of Transcend will expand the delivery of our innovative voice and Clinical Language Understanding solutions especially to small- and mid-size hospitals,” said Janet Dillione, executive vice president and general manager of Nuance’s Healthcare business. “With Transcend, we will drive change and improvement to the way these hospitals capture and leverage clinical information. The acquisition is a natural extension of Nuance’s existing healthcare business, and will strengthen our solution and services portfolio, as well as enhance our profitability.”

Nuance has agreed to acquire Transcend through a cash tender offer of $29.50 per Transcend share, representing an approximately 30 percent premium over Transcend’s 90-day volume weighted average share price. The transaction has been unanimously approved by the board of directors of each company. Based on Transcend’s 11.1 million diluted weighted average shares outstanding as of December 31, 2011, the acquisition is valued at approximately $300 million, net of Transcend’s estimated cash at closing. The transaction is expected to close in the second half of Nuance’s fiscal 2012, subject to regulatory approval and other conditions.

Nuance expects the acquisition in fiscal 2013 to add between $140 million and $150 million in revenue; non-GAAP earnings between $0.08 and $0.09 per share; and, GAAP earnings between $0.02 and $0.03 per share. See “Discussion of Non-GAAP Financial Measures” below for further information.

The addition of Transcend brings many advantages and synergies to:

• Accelerate Growth within the Small- to Mid-Size Hospital Market – Transcend brings operational excellence and customer satisfaction, as well as a leading position with national Group Purchasing Organizations (GPOs) particularly within the small- to mid-size hospital market. Greater access to these organizations will expand the delivery of Nuance’s voice-driven and Clinical Language Understanding solutions in this segment and in turn will contribute growing revenue streams for Nuance’s healthcare business.
• Strengthen Services for Healthcare Organizations – With Transcend, Nuance will gain additional medical transcription and editing capacity for its healthcare offerings. Together, the combined organization will help a broader set of healthcare organizations achieve cost effective, efficient clinical documentation workflow.
• Drive Recurring Revenue and Enhance Profitability – The acquisition of Transcend is a natural extension of Nuance’s existing healthcare business that affords a stable, recurring revenue stream from its strong customer base and will enhance profitability within the division.

“Nuance recognized Transcend’s services experience and excellence and saw real benefit in adding Transcend’s employees and management team to its healthcare business,” said Larry G. Gerdes, CEO of Transcend. “Both Nuance and Transcend share a vision to reduce healthcare costs through technology and increased efficiencies. The strength of the combined organization will truly benefit the industry and we look forward to providing Transcend customers access to Nuance’s leading HIT technology.”

Key members of the Transcend management team will play integral roles in strengthening Nuance’s position in the healthcare industry, including Susan McGrogan, Transcend’s president and chief operating officer, and Lance Cornell, Transcend’s chief financial officer.

The tender offer is expected to commence on or before March 20, 2012. The offer will be open for a period of not less than 20 business days from its commencement and will be conditioned upon valid acceptances of the offer in respect of shares representing at least a majority of the outstanding Transcend shares on a fully diluted basis as well as other closing conditions, including receipt of required regulatory approval. The tender offer will be followed by a merger in which each Transcend share not acquired in the tender offer will be converted into the right to receive $29.50 per share in cash, without interest. The transaction will be financed through cash on hand at Nuance.

Transcend Services, Inc.
Transcend Services, Inc. (NASDAQ: TRCR) provides premium quality transcription and clinical documentation services to the healthcare industry. Its services encompass a wide range of solutions - people, products and processes - designed to turn medical dictation into meaningful electronic documents. Transcend provides its clients with exceptional quality, turnaround time and service so that they can focus on what matters most – their patients.  For more information, visitwww.Transcendservices.com .

Nuance Healthcare 
Nuance Healthcare, a division of Nuance Communications, is the market leader in providing clinical understanding solutions that accurately capture and transform the patient story into meaningful, actionable information.  Thousands of hospitals, providers and payers worldwide trust Nuance voice-enabled clinical documentation and analytics solutions to facilitate smarter, more efficient decisions across the healthcare enterprise.  These solutions are proven to increase clinician satisfaction and HIT adoption, supporting organizations to achieve Meaningful Use of EHR systems and transform to the accountable care model.  Recognized as “Best-in-KLAS” 2004-2011 for Speech Recognition we invite you to learn more, http://www.nuance.com/for-healthcare/index.htm.

Nuance Communications, Inc.
Nuance Communications, Inc. (NASDAQ: NUAN) is a leading provider of voice and language solutions for businesses and consumers around the world.  Its technologies, applications and services make the user experience more compelling by transforming the way people interact with devices and systems. Every day, millions of users and thousands of businesses experience Nuance’s proven applications.  For more information, please visit www.nuance.com.